Skip to main content

. 1961 Feb;40(2):205–214. doi: 10.1172/JCI104246

STUDIES ON THE DIFFERENCES IN ACTIVITY OF LUNG AND BRAIN THROMBOPLASTIN

Harvey J Weiss ¹, James W Eichelberger Jr ¹, William H Crosby ¹

PMCID: PMC290712 PMID: 13784066

205

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BASSEN F. A. The variability of prothrombin time determinations with standardized thromboplastin preparations. J Mt Sinai Hosp N Y. 1955 Jul-Aug;22(2):112–118. [PubMed] [Google Scholar]
CALDWELL M. J., PRIEST E. M. A different concept of prothrombin time control for anticoagulative therapy. Am Heart J. 1958 Nov;56(5):737–741. doi: 10.1016/0002-8703(58)90216-3. [DOI] [PubMed] [Google Scholar]
HUNTER R. B., TUDHOPE G. R. Mode of action of tromexan. Lancet. 1953 Apr 25;1(6765):821–823. doi: 10.1016/s0140-6736(53)91951-5. [DOI] [PubMed] [Google Scholar]
JENKINS J. S. The thromboplastic activity of Russell's viper venom and its relationship to factor VII. J Clin Pathol. 1954 Nov;7(4):287–289. doi: 10.1136/jcp.7.4.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
KOPPEL J. L., ARSCOTT P. M., FRIEDMAN L. H., OLWIN J. H. Differences in tissue thromboplastins and their influence on the control of anticoagulant therapy. Surgery. 1958 Jan;43(1):94–101. [PubMed] [Google Scholar]
LANCHANTIN G. F., WARE A. G. Identification of a thromboplastin inhibitor in serum and in plasma. J Clin Invest. 1953 Apr;32(4):381–389. doi: 10.1172/JCI102749. [DOI] [PMC free article] [PubMed] [Google Scholar]
MANN F. D., BARKER N. W., HURN M. The effect of dicoumarol on co-thromboplastin, a factor in blood concerned with the conversion of prothrombin to thrombin. Blood. 1951 Sep;6(9):838–844. [PubMed] [Google Scholar]
MANN F. D., HURN M. M. The complex mechanisms of the quick prothrombin test and the effect of dicumarol. Am J Clin Pathol. 1950 Mar;20(3):225–232. doi: 10.1093/ajcp/20.3.225. [DOI] [PubMed] [Google Scholar]
MANN F. D., HURN M. Co-thromboplastin, a probable factor in coagulation of blood. Am J Physiol. 1951 Jan;164(1):105–110. doi: 10.1152/ajplegacy.1950.164.1.105. [DOI] [PubMed] [Google Scholar]
OWREN P. A. La proconvertine. Rev Hematol. 1952;7(2):147–155. [PubMed] [Google Scholar]
RAPAPORT S., AAS K., OWREN P. A. The clotting action of Russell viper venom. Blood. 1954 Dec;9(12):1185–1194. [PubMed] [Google Scholar]
SCHAEFER E. H., Jr, THERRIAULT D. G., JENSEN H. Studies on a prothrombin conversion inhibitor fraction from rabbit serum. J Appl Physiol. 1955 Nov;8(3):300–304. doi: 10.1152/jappl.1955.8.3.300. [DOI] [PubMed] [Google Scholar]
SHAPIRO S. Comparison of thromboplastic activity of lyophilized preparations of thromboplastin. Am J Clin Pathol. 1960 Mar;33:220–228. doi: 10.1093/ajcp/33.3.220. [DOI] [PubMed] [Google Scholar]
VERSTRAETE M., CLARK P. A., WRIGHT I. S. Evaluation of prothrombin times performed with different thromboplastins. Acta Med Scand. 1959 Feb 25;163(2):105–114. doi: 10.1111/j.0954-6820.1959.tb10386.x. [DOI] [PubMed] [Google Scholar]
VERSTRAETE M., CLARK P. A., WRIGHT I. S. Use of different tissue thromboplastins in the control of anticoagulant therapy. Circulation. 1957 Aug;16(2):213–226. doi: 10.1161/01.cir.16.2.213. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES